عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
0123813263
9780123813268
dltt
Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors /
[Book]
editor, Erkki Nissinen
201012
xii, 323 pages :
illustrations ;
24 cm
International review of neurobiology ;
v. 95
Includes bibliographical references and index
Cover; International Review of Neurobiology; Copyright; Contributors; Preface; Introductory Remarks: Catechol-O-Methyltransferase Inhibition -- An Innovative Approach To Enhance l-Dopa Therapy In Parkinson'S D; The Catechol-O-Methyltransferase Gene: Its Regulation and Polymorphisms; Distribution and Functions of Catechol-O-Methyltransferase Proteins: Do Recent Findings Change The Picture?; Catechol-O-Methyltransferase Enzyme: Cofactor S-Adenosyl-l-Methionine And Related Mechanisms; Biochemistry And Pharmacology Of Catechol-O-Methyltransferase Inhibitors
0
"Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description
Catecholamines
Parkinson's disease-- Chemotherapy
Psychotropic drugs
Nissinen, Erkki
20101221092631.0
rda
مطالعه متن کتاب [Book]
Y
